Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial

ClinicalTrials.gov ID: NCT04839354

Public ClinicalTrials.gov record NCT04839354. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The trial is designed to test intravenous (IV) arginine therapy in children with sickle cell disease (SCD) and vaso-occlusive painful episodes (VOE) to further knowledge on efficacy and safety of this orphan drug.

Study identification

NCT ID
NCT04839354
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Claudia R. Morris
Other
Enrollment
271 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
3 Years to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 20, 2021
Primary completion
Jul 10, 2024
Completion
Jul 10, 2024
Last update posted
Jun 22, 2026

2021 – 2024

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027
UCSF Benioff Children's Hospital San Francisco California 94158
Children's National Medical Center Washington D.C. District of Columbia 20010
Children's Healthcare of Atlanta at Hughes Spalding Atlanta Georgia 03322
Children's Healthcare of Atlanta at Egleston Atlanta Georgia 30322
Washington University/St. Louis Children's Hospital St Louis Missouri 63110
Nationwide Children's Hospital Columbus Ohio 43205
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Texas Children's Hospital/Baylor College of Medicine Houston Texas 77030
Medical College of Wisconsin/Wisconsin Children's Hospital Wauwatosa Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04839354, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2026 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04839354 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →